Evidence map›Paper›PMID 37189341›Full record

ReviewBiomolecules2023

Regulation of the SUV39H Family Methyltransferases: Insights from Fission Yeast.

Rinko Nakamura, Jun-Ichi Nakayama

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rinko NakamuraDivision of Chromatin Regulation, National Institute for Basic Biology, Okazaki 444-8585, Japan.ORCID 0000-0001-5248-3540
Jun-Ichi NakayamaDivision of Chromatin Regulation, National Institute for Basic Biology, Okazaki 444-8585, Japan.ORCID 0000-0002-5597-8239
National Institute for Basic Biology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histones, which make up nucleosomes, undergo various post-translational modifications, such as acetylation, methylation, phosphorylation, and ubiquitylation. In particular, histone methylation serves different cellular functions depending on the location of the amino acid residue undergoing modification, and is tightly regulated by the antagonistic action of histone methyltransferases and demethylases. The SUV39H family of histone methyltransferases (HMTases) are evolutionarily conserved from fission yeast to humans and play an important role in the formation of higher-order chromatin structures called heterochromatin. The SUV39H family HMTases catalyzes the methylation of histone H3 lysine 9 (H3K9), and this modification serves as a binding site for heterochromatin protein 1 (HP1) to form a higher-order chromatin structure. While the regulatory mechanism of this family of enzymes has been extensively studied in various model organisms, Clr4, a fission yeast homologue, has made an important contribution. In this review, we focus on the regulatory mechanisms of the SUV39H family of proteins, in particular, the molecular mechanisms revealed by the studies of the fission yeast Clr4, and discuss their generality in comparison to other HMTases.

Indexed as

SchizosaccharomycesSchizosaccharomyces pombe ProteinsCell Cycle ProteinsChromatinHeterochromatinHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHistonesHumansCell Cycle ProteinsChromatinclr4 protein, S pombeHeterochromatinHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHistonesSchizosaccharomyces pombe ProteinsautoregulationchromodomainClr4fission yeasthistone methylationhistone methyltransferasesSET domainSUV39Hubiquitylation

Identifiers

PMID37189341
PMCPMC10135481
OpenAlexW4361005345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.